Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Plasminogen' and Ligand = 'BDBM50431219'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Plasminogen (Homo sapiens (Human))	BDBM50431219 (CHEMBL2332616) Show SMILES CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O |r,wU:57.71,41.50,34.34,13.17,4.4,88.91,wD:71.77,52.54,28.31,21.20,8.8,82.85,(43.75,-11.47,;44.15,-12.95,;45.63,-13.35,;43.06,-14.04,;43.46,-15.52,;42.37,-16.61,;40.89,-16.22,;40.49,-14.73,;39.79,-17.31,;40.19,-18.8,;38.31,-16.92,;37.22,-18.01,;37.62,-19.49,;35.73,-17.61,;35.33,-16.12,;36.42,-15.03,;36.02,-13.54,;37.91,-15.43,;34.65,-18.7,;33.16,-18.3,;32.76,-16.81,;32.07,-19.39,;32.55,-20.87,;31.05,-21.61,;29.88,-20.42,;30.64,-18.93,;30.05,-17.5,;30.99,-16.28,;28.52,-17.31,;27.59,-18.52,;26.07,-18.32,;27.94,-15.88,;26.41,-15.68,;25.47,-16.9,;25.82,-14.25,;26.84,-13.08,;25.73,-11.81,;24.19,-12.47,;24.33,-14.14,;23.24,-15.23,;23.64,-16.72,;21.75,-14.83,;21.35,-13.35,;19.86,-12.95,;19.46,-11.47,;17.97,-11.06,;17.57,-9.57,;18.66,-8.48,;16.08,-9.18,;20.66,-15.92,;19.17,-15.52,;18.77,-14.04,;18.08,-16.61,;18.49,-18.1,;16.6,-16.22,;15.51,-17.31,;15.91,-18.8,;14.03,-16.92,;13.62,-15.43,;14.71,-14.34,;16.23,-14.57,;16.92,-13.2,;15.84,-12.12,;15.91,-10.59,;14.63,-9.75,;13.26,-10.45,;13.18,-11.98,;14.47,-12.82,;12.94,-18.01,;11.45,-17.61,;11.04,-16.12,;10.36,-18.7,;10.76,-20.18,;12.25,-20.58,;8.87,-18.3,;7.78,-19.39,;8.18,-20.88,;6.3,-18.99,;5.21,-20.08,;44.95,-15.93,;45.35,-17.41,;46.04,-14.83,;47.53,-15.23,;47.92,-16.72,;49.41,-17.11,;48.61,-14.14,;48.21,-12.65,;50.1,-14.53,;51.19,-13.45,;50.79,-11.95,;51.88,-10.87,;51.48,-9.38,;49.99,-8.98,;52.56,-8.29,;52.67,-13.84,;53.76,-12.75,;53.08,-15.33,)| Show InChI InChI=1S/C61H96N18O15S3/c1-30(2)22-39(51(84)68-33(6)50(83)73-40(23-31(3)4)53(86)76-43(28-96)55(88)72-38(60(93)94)17-18-47(63)80)75-56(89)45-15-11-21-79(45)59(92)44(29-97)77-57(90)46-16-10-20-78(46)58(91)37(14-9-19-66-61(64)65)71-49(82)32(5)69-52(85)41(74-54(87)42(27-95)70-48(81)25-62)24-34-26-67-36-13-8-7-12-35(34)36/h7-8,12-13,26,30-33,37-46,67,95-97H,9-11,14-25,27-29,62H2,1-6H3,(H2,63,80)(H,68,84)(H,69,85)(H,70,81)(H,71,82)(H,72,88)(H,73,83)(H,74,87)(H,75,89)(H,76,86)(H,77,90)(H,93,94)(H4,64,65,66)/t32-,33-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Similars	Article PubMed	>1.20E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Ecole Polytechnique F�d�rale de Lausanne EPFL Curated by ChEMBL					Assay Description Inhibition of human plasmin using H-D-Val-Leu-Lys-AMC as substrate assessed as residual activity by fluorescence plate reader analysis				J Med Chem 56: 3742-6 (2013) Article DOI: 10.1021/jm400236j BindingDB Entry DOI: 10.7270/Q2GX4CXF
					More data for this Ligand-Target Pair